¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sclerosing osteogenic sarcoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing keratitis
    °æÈ­°¢¸·¿°
  • sclerosing liposarcoma
    °æÈ­Áö¹æÀ°Á¾
  • sclerosing mastoiditis
    °æÈ­²ÀÁöµ¹±â¿°, °æÈ­À¯µ¹¿°
  • sclerosing retroperitonitis
    °æÈ­Èĺ¹¸·¿°, °æÈ­¹è¸·µÚ¿°
  • sclerosing solution
    °æÈ­¾×
  • alveolar soft part sarcoma
    Æ÷»ó¿¬ºÎÀ°Á¾
  • clear cell sarcoma
    Åõ¸í¼¼Æ÷À°Á¾
  • Ewing¡¯s sarcoma
    À¯À×À°Á¾
  • endometrial stromal sarcoma
    Àڱ󻸷¹öÆÀÁúÀ°Á¾, Àڱ󻸷°£ÁúÀ°Á¾
  • epithelioid sarcoma
    »óÇǸð¾çÀ°Á¾
  • granulocytic sarcoma
    °ú¸³±¸À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ßÃâÇ÷À°Á¾
  • Kaposi sarcoma
    Ä«Æ÷½ÃÀ°Á¾
  • osteoblastic sarcoma
    »À¸ð¼¼Æ÷À°Á¾, °ñ¸ð¼¼Æ÷À°Á¾
  • osteoid sarcoma
    Dz»ÀÀ°Á¾, À¯°ñÀ°Á¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • polymorphous sarcoma
    ´ÙÇüÅÂÀ°Á¾, ¿©·¯ÇüÅÂÀ°Á¾
  • pseudo-Kaposi sarcoma
    °ÅÁþÄ«Æ÷½ÃÀ°Á¾
  • reticulum cell sarcoma
    ±×¹°¼¼Æ÷À°Á¾, ¼¼¸Á¼¼Æ÷À°Á¾
  • sarcoma
    À°Á¾
  • spindle cell sarcoma
    ¹æÃß¼¼Æ÷À°Á¾
  • synovial sarcoma
    (¢¡synoviosarcoma) À±È°¸·À°Á¾
  • thymic sarcoma
    °¡½¿»ùÀ°Á¾
  • sclerosing adenitis
    °æÈ­»ù¿°
  • sclerosing adenosis
    °æÈ­»ùÁõ
  • sclerosing agent
    °æÈ­Á¦
  • sclerosing angioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°
  • subacute sclerosing encephalitis
    ¾Æ±Þ¼º°æÈ­³ú¿°
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • sclerosing gastritis
    °æÈ­À§¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • african kaposis sarcoma
    ¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾(¡­ë¿ðþ)
  • gastric sarcoma
    À§À°Á¾.
  • granulocytic sarcoma
    °ú¸³¼¼Æ÷ À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ß¼º ÃâÇ÷¼º À°Á¾
  • polymorphous sarcoma
    ´ÙÇü(¼º) À°Á¾(Òýû¡(àõ) ë¿ðþ)
  • pulmonary sarcoma
    ÆóÀ°Á¾(øËë¿ðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • african kaposis sarcoma
    ¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾(¡­ë¿ðþ)
  • avian sarcoma virus
    Á¶·ùÀ°¾ÆÁ¾¹ÙÀÌ·¯½º
  • avian sarcoma virus
    Á¶·ù À°¾ÆÁ¾¹ÙÀÌ·¯½º
  • clear cell sarcoma
  • endometrial stromal sarcoma
    Àڱ󻸷 °£ÁúÀ°Á¾
  • epithelioid sarcoma
    »óÇǾç À°Á¾
  • ewings sarcoma
    À¯À®À°Á¾(¡­ë¿ðþ)
  • gastric sarcoma
    À§À°Á¾.
  • granulocytic sarcoma
    °ú¸³¼¼Æ÷ À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ß¼º ÃâÇ÷¼º À°Á¾
  • kaposi s sarcoma
    Ä«Æ÷½ÃÀ°Á¾(ë¿ðþ)
  • kaposis sarcoma
    Ä«Æ÷½ÃÀ°Á¾, Kaposi À°Á¾
  • leukemia sarcoma complex viruses
    ¹éÇ÷º´-À°Á¾¹ÙÀÌ·¯½º±º(ÛÜúìÜ»ë¿ðþ¡­ÏØ).
  • mixed mullerian sarcoma
    È¥ÇÕ ¹Á·¯¸®¾È À°Á¾
  • murine sarcoma virus
    ¸¶¿ì½º À°Á¾¹ÙÀÌ·¯½º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ASHN acute sclerosing hyaline necrosis
FSGN focal sclerosing glomerulonephritis
NSHD nodular sclerosing Hodgkin disease
PSC patient services coordination; Porter-Silber chromogen; posterior subcapsular cataract; primary scle...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NS Nodular Sclerosing
PSC Primary Sclerosing Cholangitis
SEP Sclerosing Encapsulating Peritonitis
SSPE Subacute Sclerosing Panencephalitis
NSHD nodular sclerosing Hodgkin disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • endometrial stromal sarcoma
    Àڱ󻸷 ±âÁú À°Á¾
    Àú¾Ç¼º°ú °í¾Ç¼º Á¾¾çÀ¸·Î ±¸ºÐµÈ´Ù. Æò±Õ ¿¬·ÉÀº 42-53¼¼ÀÌ°í ¹Ý¼ö À̻󿡼­ Æó°æ±â ÀÌÀü¿¡ »ý±ä´Ù. ÁÖ Áõ»óÀº ÀÌ»ó ÀÚ±ÃÃâÇ÷, ÁÖ±âÀû ºÎÁ¤ Àڱà ÃâÇ÷ ¹× º¹ºÎ µ¿Åë µîÀÌ´Ù. ÈçÈ÷ ÀÚ±ÃÀÌ Ä¿Áö¹Ç·Î ÀÓ»óÀûÀ¸·Î ÀڱñÙÁ¾À¸·Î Áø´ÜµÉ ¶§°¡ ¸¹´Ù. À°¾ÈÀûÀ¸·Î Àú¾Ç¼ºÀº Àß °æ°èµÇÁö ¾Ê´Â Á¾±«°¡ ÁÖÀ§ÀÇ ±ÙÃþÀ¸·Î Ȳ°¥»öÀÇ ¼Ò°áÀýó·³ ħÀ±Çذ¡´Â °Í°ú ¶Ñ·ÇÇÑ Á¾±« Çü¼º ¾øÀÌ ÀڱñÙÃþÀÌ ¹Ì¸¸¼ºÀ¸·Î ºñÈĵǴ °Í, Á¾±«°¡ ±ÙÁ¾Ã³·³ ÁÖº¯ ºÎÀ§¿¡¼­ À¶±âµÇ¾î º¸ÀÌÁö¸¸ Àý´Ü¸éÀÌ È²°¥»öÀÌ°í ¿¬ÇÏ¿© ±ÙÁ¾°ú´Â ´Ù¸¥ °æ¿ìÀÇ ¼¼ °¡Áö ÇüŸ¦ ÃëÇÑ´Ù. °í¾Ç¼ºÀº ¿¬ÇÏ°í °í±â µ¢¾î¸® °°Àº ¿ëÁ¾¼º Á¾¾çÀ¸·Î Àڱó» °­ ¾ÈÀ¸·Î ÅÍÁ® ³ª¿Í ³»°­À» ä¿ì°Ô µÈ´Ù. ´Ù¹ß¼ºÀ̰í ÃâÇ÷°ú ±«»ç¸¦ ÈçÈ÷ º¸À̸ç Àڱñ٠ÃþÀ¸·Î ħÀ±ÇÑ´Ù.
  • Ewing's sarcoma
    Ewing À°Á¾, À¯À× À°Á¾
    °ñ¼ö·ÎºÎÅÍ ¹ß»ýÇÏ´Â ¾Ç¼º °ñ Á¾¾çÀÎ ³»ÇǼº °ñ¼öÁ¾À¸·Î¼­ ÅëÁõ, ¹ß¿­, ¹éÇ÷±¸ Áõ°¡ÁõÀ» µ¿¹ÝÇϸ鼭 Àå°ñ¿¡¼­ °¡Àå ÈçÇÏ´Ù.
  • Kaposi's sarcoma
    Ä«Æ÷½Ã À°Á¾, Kaposi À°Á¾
    ÇǺο¡¼­ ¹ß»ýÇϴ ƯÀÌÇÑ Ç÷°üÁ¾. ¼­¼­È÷ ÁøÇàµÇ´Â ¾Ç¼º °£¿± Á¶Á÷ Á¾¾çÀ¸·Î, 40-70¼¼ ³²ÀÚÀÇ ÇÏÁö¿¡¼­ È£¹ßÇÑ´Ù. ÀÓ»óÀûÀ¸·Î º´¼Ò´Â ÇǺΠ¾î´À ºÎÀ§¿¡¼­³ª ³ªÅ¸³¯ ¼ö ÀÖÀ¸³ª Ãʱ⿡´Â ´Ù¹ß¼ºÀÎ ÀÛÀº ÀûÀÚ»ö ¹Ý, ¶Ç´Â ±¸Áø°ú °áÀýÀÇ ÇüÅ·Π³ªÅ¸³­´Ù. °á±¹ È®´ëµÇ°í ¼­·Î À¶ÇÕÇÏ¿© ÀûÀÚ»ö Ç÷°ü Á¾¾çÀ» Çü¼ºÇÑ´Ù. ÈÄõ¼º ¸é¿ª °áÇÌÁõÀ̳ª ¾ÆÇÁ¸®Ä«Çü¿¡¼­´Â Àü½ÅÀûÀ¸·Î Àß ¹ß»ýÇÏ¸ç ¸ñ ¸²ÇÁÀý, Ÿ¾×¼±, ¾È¿Í¼± µéÀÌ º¸Åë óÀ½¿¡ ħ¹üµÇ°í, ³»ºÎ Àå±âÀÇ Ä§¹üÀº ´ë°³´Â ÇÕº´ÁõÀÌ´Ù.
  • oral kaposis sarcoma
    ±¸³» Ä«Æ÷½Ã ¾ÏÁ¾
  • osteoblastic sarcoma
    °ñÇü¼º¼º À°Á¾
  • polymorphous sarcoma
    ´ÙÇü¼º À°Á¾
  • Rous sarcoma
    ¶ó¿ì½º À°Á¾
    1910³â F.P. ¶ó¿ì½º°¡ ¹ß°ßÇÑ À̽ÄÀÌ °¡´ÉÇÑ ´ßÀÇ ¹ÙÀÌ·¯½º ¾ÏÀ¸·Î ¾Ë·ÁÁø ¹æÃßÇü ¼¼Æ÷À°Á¾. À°Á¾ ¼¼Æ÷¸¦ ÇÔÀ¯ÇÏÁö ¾Ê´Â ¿©°ú¾×¿¡ ÀÇÇÏ¿© À̽ÄÀÌ °¡´ÉÇÏ´Ù´Â °ÍÀ» ¹ß°ßÇϰí, ±× ÈÄ¿¡ ±× ÀÎÀÚ°¡ ¹ÙÀÌ·¯½º¶ó´Â °ÍÀ» ¹ß°ßÇÔÀ¸·Î½á ³ëº§ »ý¸®, ÀÇÇлóÀ» ¹Þ¾Ò´Ù. ¿À´Ã³¯ ¹ß¾Ï ¹ÙÀÌ·¯½ºÀÇ ¿¬±¸¿¡ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ´Ù.
  • sarcoma
    À°Á¾
    żºÀÇ °áÇÕ Á¶Á÷°ú Èí»çÇÑ ¹°Áú·Î µÈ Á¾¾çÀ¸·Î¼­, Á¶Á÷Àº ¼¼¼¶À¯ ¶Ç´Â ±ÕÁú ¹°Áú¿¡ Æ÷¸ÅµÈ Ä¡¹ÐÇÏ°Ô Ã¤¿öÁø ¼¼Æ÷·Î ÀÌ·ç¾îÁ®ÀÖ´Ù. À°Á¾Àº Á¾Á¾ °íµµ·Î ¾Ç¼ºÀÌ´Ù.
  • synovial sarcoma
    Ȱ¸·¼º À°Á¾
    Ȱ¾×¸·À̳ª °üÀý ÁÖÀ§ ¶Ç´Â °ÇÃÊ µî¿¡¼­ ¹ß»ýµÇ´Â ¾Ç¼º Á¾¾çÀ̸ç Ȱ¾×¸· ¼¼Æ÷¿¡¼­ ¾ß±âµÈ´Ù. ¸¹Àº ¿¹°¡ ½½°üÀý¿¡¼­ ¹ß»ýÇÏÁö¸¸, µÎ°æºÎ¿¡¼­µµ ¾Ç°üÀý ÁÖÀ§¿¡¼­ ¹ß»ýµÈ´Ù. ÀÓ»óÀûÀ¸·Î ÀþÀº ¿¬·ÉÃþ¿¡¼­ ¹ß»ýµÇ¸ç µ¿ÅëÀ» À¯¹ßÇÏÁö´Â ¾Ê´Â´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
sclerosing keratitis Inflammation of the cornea complicating scleritis; characterised by opacification of the corneal stroma.
(05 Mar 2000)
sclerosing leukoencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
sclerosing mastoiditis A chronic mastoiditis in which the trabeculae are greatly thickened, almost or entirely obliterating the cells.
(05 Mar 2000)
sclerosing of varicose veins A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
sclerosing osteitis Fusiform thickening or increased density of bones, of unknown cause; it has been considered a form of chronic nonsuppurative osteomyelitis.
Synonym: condensing osteitis, Garre's disease.
Osteitis tuberculosa multiplex cystica, an osteitis of tuberculous origin, marked by numerous small cavities in the osseous substance.
Synonym: Jungling's disease.
(05 Mar 2000)
sclerosing solutions Chemical agents injected into veins to cause localised thrombosis and eventual fibrosis and obliteration of the vessels. They are used in the treatment of varicose veins, haemorrhoids, gastric and oesophageal varices, and peptic ulcer haemorrhage.
(12 Dec 1998)
sclerosing therapy A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
subacute sclerosing leukoencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
subacute sclerosing panencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
focal sclerosing glomerulopathy Focal, segmental glomerulosclerosis reported in adults and children with normal serum complement, progressing to chronic glomerulonephritis.
(05 Mar 2000)
alveolar soft part sarcoma <tumour> A malignant tumour formed of a reticular stroma of connective tissue enclosing aggregates of large round or polygonal cells; occurs in subcutaneous and fibromuscular tissues.
(05 Mar 2000)
ameloblastic sarcoma <tumour> A rapidly growing, painful, destructive, radiolucent odontogenic tumour that usually arises through malignant change in the mesenchymal component of a pre-existing ameloblastic fibroma.
Synonym: ameloblastic sarcoma.
(05 Mar 2000)
angiolithic sarcoma <tumour> A firm cellular neoplasm derived from fibrous tissue of the meninges, choroid plexus, and certain other structures associated with the brain, characterised by the formation of multiple, discrete, concentrically laminated, calcareous bodies (psammoma bodies); most of these neoplasms are histologically benign, but may lead to severe symptoms as a result of compressing the brain.
Synonym: angiolithic sarcoma, sand tumour, Virchow's psammoma.
(05 Mar 2000)
avian leukaemia-sarcoma complex A term applied to a group of transmissible virus-induced diseases of chickens causing sarcoma, myeloblastosis, erythroblastosis, leukosis, osteopetrosis, and lymphomatosis. These agents are closely related viruses (avian leukosis-sarcoma virus) causing prolferation of immature erythroid, myeloid, or lymphoid cells, a division of the RNA tumour viruses (subfamily Oncovirinae) causing the avian leukosis-sarcoma complex of diseases; the viruses are subgrouped according to antigenic characteristics and growth in defined types of tissue culture cells.
Synonym: avian erythroblastosis virus, avian leukosis-sarcoma virus, avian lymphomatosis virus, avian myeloblastosis virus, avian sarcoma virus, fowl erythroblastosis virus, fowl lymphomatosis virus, fowl myeloblastosis virus.
(05 Mar 2000)
avian leukosis-sarcoma virus avian leukosis-sarcoma complex
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á